A detailed history of Lgt Group Foundation transactions in Boston Scientific Corp stock. As of the latest transaction made, Lgt Group Foundation holds 172,724 shares of BSX stock, worth $15 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares
172,724
Previous 573,791 69.9%
Holding current value
$15 Million
Previous $44.2 Million 67.24%
% of portfolio
0.24%
Previous 0.68%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$72.96 - $84.0 $29.3 Million - $33.7 Million
-401,067 Reduced 69.9%
172,724 $14.5 Million
Q2 2024

Aug 07, 2024

BUY
$67.33 - $77.71 $38.6 Million - $44.6 Million
573,455 Added 170671.12%
573,791 $44.2 Million
Q1 2024

May 14, 2024

BUY
$57.6 - $68.62 $19,353 - $23,056
336 New
336 $23,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $125B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Lgt Group Foundation Portfolio

Follow Lgt Group Foundation and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lgt Group Foundation, based on Form 13F filings with the SEC.

News

Stay updated on Lgt Group Foundation with notifications on news.